Unlike neurons, glial cells are able to proliferate in the postnatal and mature brain (Korr, 1986) , and gliogenesis continues throughout childhood in most mammals (Gensert and Goldman, 1996) . In the adult, proliferation-competent glial cells are thought to participate in glial scar formation (reactive gliosis). Gliosis may involve induction of formerly postmitotic cells to dedifferentiate and proliferate (Hatten et al., 1991) and can be associated with trauma (Reier, 1986) , infarct lesions (Kraig and Jaeger, 1990 ), Alzheimer's plaques (Murphy et al., 1992) , epileptic seizure foci (Pollen and Trachtenberg, 1970) , neurotoxicity (Niquet et al., 1994) , ischemic injury (Kraig and Jaeger, 1990) , and mechanical injury (Reier, 1986) . Thus, gliogenesis and gliosis are temporally and f unctionally distinct modes of glial proliferation, the former prevailing during early brain development and the latter an integral part of wound healing.
Proliferating glial cells differ from nonproliferating cells in their growth factor and cytokine responsiveness (Westermark et al., 1995) , cytoskeletal protein expression (Dahl et al., 1981; Gallo and Armstrong, 1995) , and electrophysiological properties. The latter have been characterized most comprehensively in O-2A glial progenitor cells, which are endowed with voltage-and ligandactivated ion channels (Bevan et al., 1987; Barres et al., 1990a,b; Sakatani et al., 1992; Gallo et al., 1994) . On commitment to either astrocyte or oligodendrocyte lineage, their ion channel complement changes markedly (Sontheimer et al., 1989; Barres et al., 1990b) . Several studies suggest that these changes are necessary in determining cell cycle progression. Specifically, the expression and/or activity of potassium channels have been linked to glial proliferation. Thus in O2-A cells (Gallo et al., 1996) , Schwann cells (Chiu and Wilson, 1989) , retinal glial cells (Puro et al., 1989) , and spinal cord astrocytes (Pappas et al., 1994) , blockade of K ϩ channels retards proliferation. Underlying mechanisms are not well understood, but studies suggest that intracellular pH (Pappas et al., 1994) or intracellular Na ϩ (Knutson et al., 1997 ) are critically important. Moreover, involvement of ion channel activity in cell cycle control has been documented for other inexcitable cells (for review, see Sontheimer, 1995) .
Little is known concerning changes in membrane properties in glial cells undergoing secondary, injury-induced proliferation, and the goal of the present study was to fill this void. Our studies were facilitated by the development of an in vitro scar model (Yu et al., 1993) , resembling reactive gliosis in many respects (Yu et al., 1993; Hou et al., 1995) . In this in vitro model, astrocytes show upregulation of both mitotic activity and glial fibrillary acidic protein (GFAP) expression, comparable to that seen in vivo (Bignami and Dahl, 1976; Armaducci, 1981; Aquino, 1988) . We compared electrophysiological properties of scar-associated glial cells with uninjured control astrocytes. On being induced to proliferate, scar-associated cells demonstrated a rapid and transient switch in K ϩ channel complement from inwardly to outwardly rectifying K ϩ channels. These changes are reminiscent of those seen during glial development, suggesting that secondary proliferation recapitulates membrane properties seen during gliogenesis. Pharmacological blockade of outwardly rectifying potas-sium currents retards glial proliferation and scar healing, suggesting that their activity is essential for these processes.
MATERIALS AND METHODS
Cell culture. Primary spinal cord astrocyte cultures were obtained from P 0 -P 1 Sprague Dawley rat pups. Pups were put on ice, and spinal cords were dissected from midcervical to lumbar regions. Tissue was excised in filter-sterilized Complete saline solution (C SS) containing the following (in mM): 137 NaC l, 5.3 KC l, 1 MgC l 2 , 25 glucose, 10 H EPES, and 3 CaCl 2 , adjusted to pH 7.2 by NaOH. Then tissue was stripped of meninges and blood vessels, minced, and incubated for 20 min at 37°C and 95%O 2 /5%C O 2 in C SS plus 0.5 mM EDTA, 1.65 mM L-cysteine, and 30 U/ml papain (Worthington, Freehold, NJ). Enzyme solution was aspirated, and tissue was rinsed with Earle's Minimal Essential Media (EM EM; Life Technologies, Grand Island, N Y) supplemented with 20 mM glucose, 10% fetal calf serum (FC S; HyC lone, L ogan, UT), 500 U/ml of penicillin /streptomycin, 1.0 mg /ml trypsin inhibitor, and 1.0 mg /ml BSA. Tissue was dissociated by trituration (20ϫ) with a fire-polished Pasteur pipette. C ells were plated on poly-ornithine/ laminin-coated 12 mm glass coverslips (MacAlaster Bicknell, New Haven, C T) at a density of 1.0 ϫ 10 6 /ml. C ells were maintained at 37°C and 95%O 2 /5%C O 2 in EM EM supplemented with 20 mM glucose, 10% FC S (HyC lone), and 500 U/ml penicillin /streptomycin. The medium was changed every 3-4 d. Cultures were Ͼ95% positively immunoreactive for GFAP (rabbit monoclonal, I NC STAR, Stillwater, M N). All chemicals were obtained from Sigma (St. L ouis, MO), unless otherwise stated.
Electrophysiolog y. Whole-cell voltage-clamp recordings were obtained via standard methods (Hamill et al., 1981) . Patch pipettes were made from thin-walled (outer diameter 1.5 mm, inner diameter 1.12 mm) borosilicate glass (TW150F-4, W PI, Sarasota, FL). Electrodes typically had resistances of 4 -6.5 M⍀ when filled with a solution containing (in mM) 145 KC l, 1 MgC l 2 , 10 EGTA, 10 H EPES sodium salt, and 0.8 mg /ml of L ucifer yellow dilithium salt, with the pH adjusted to 7.3 with Tris(hydroxymethyl)aminomethane (Tris). Recordings were made from astrocytes Ͼ8 d in vitro on the stage of an inverted Nikon Diaphot microscope equipped with Hoffman Modulation Contrast optics. C ells were perf used continuously at room temperature with saline containing (in mM) 130 NaC l, 5 KC l, 1.2 MgSO 4 , 1.6 Na 2 HPO 4 , 0.4 NaH 2 PO 4 , 10.5 glucose, and 32.5 H EPES, adjusted to pH 7.4 with NaOH. Added to the saline just before recording was 1 mM CaCl 2 .
Current recordings were obtained with an Axopatch 1-B amplifier (Axon Instruments, Foster C ity, CA). Current signals were low-passfiltered at 2 kHz and were digitized on-line at 2.5-333 kHz, using a Digidata 1200 digitizing board (Axon Instruments) interfaced with an I BM-compatible computer (Dell P100). Data acquisition and storage were conducted with the use of pC lamp 6 (Axon Instruments). C ell capacitances and series resistances were measured directly from the amplifier, and series resistance compensation was set at ϳ80% to reduce voltage errors. The entrance potential of the cell served as an estimate of the resting potential of the cell. Unless otherwise stated, currents were leak-subtracted (P/5). Currents in response to varied voltage steps were analyzed and measured with C lampfit (Axon Instruments); the resulting raw data were graphed and plotted with Origin 4.0 (MicroC al, Northampton, M A). Ionic conductances were calculated by dividing peak current amplitudes by the ionic driving force [I peak /(E m Ϫ E rev )]. The ionic reversal potentials calculated for the solutions used were as follows: E K ϭ Ϫ86 mV; E Na ϭ 65 mV; E C l ϭ 2 mV. Specific conductance densities (pS/pF) were calculated by dividing the ionic conductance by the cell capacitance. Unless otherwise stated, all values are reported as mean Ϯ SEM, with n being the number of cells sampled. Normalized peak conductance values were plotted versus membrane potential for individual cells, and the resulting activation and inactivation curves were fit to the Boltzmann equation (given below). Then the mean and SD of these curves were plotted and fit to the Boltzmann equation:
Phase contrast photomicrographs of individual cells were acquired during recording by using a CCD camera and a frame grabber (Snappy; Play, Incorporated, Rancho Cordova, CA). Pharmacolog y. Pharmacological properties of K ϩ currents were determined by perf using with the following compounds diluted in recording media: 100 M CsCl or 2 mM 4-aminopyridine (4-AP). For experiments determining the sensitivity to tetraethylammonium chloride (TEA-C l), 20 mM NaC l and 20 mM H EPES were removed from the normal bath solution and replaced with 40 mM TEA-C l. To determine the tetrodotoxin (TTX) sensitivity of sodium currents, we diluted TTX in bath solution and applied it by microperf usion directly above the cell. To facilitate kinetic recordings, we isolated Na ϩ currents by recording in a solution that replaced the KC l in the pipette solution with 20 mM TEA-C l, 30 mM glucose, and 125 mM N-methyl-D-glucamine (NMDG).
Bromodeoxyuridine (BrdU) correlation. BrdU was incorporated into proliferating cells during S-phase. T wo hours before electrophysiological recording, cells were incubated with BrdU labeling reagent (Zymed Laboratories, South San Francisco, CA). Recorded cells were filled with L ucifer yellow during recording (see pipette solution), and postrecordings were fixed for at least 24 hr in the dark in 4% paraformaldehyde. A biotinylated mouse anti-BrdU monoclonal (Zymed) was used as the primary antibody, followed by a rhodamine-conjugated avidin /streptavidin secondary antibody (Vector Laboratories, Burlingame, CA). BrdUcorrelated cells were identified individually by their Hoffman contrast photomicrograph taken during recording and by double labeling for L ucifer yellow and BrdU.
Proliferation assays. Mechanically scarred coverslips and their agematched controls were labeled for 2 hr with BrdU at various time points postscar, rinsed, and fixed in 70% ethanol at Ϫ20°C and stained by a biotinylated BrdU antibody and a streptavidin-peroxidase and diaminobenzidine (DAB) developing kit with a hematoxylin counterstain (Zymed). At a magnification of 20ϫ, eight random fields of fixed size were selected, and a ratio of BrdU-positive/negative cells was calculated per total number of cells. For scar preparations, fields of identical size and cell numbers as the control fields, but adjacent to the scar, were selected. Changes in the number of proliferating cells were expressed as a percentage of control.
Incorporation of 3 H-thymidine was used as a quantitative marker for DNA synthesis. C ells were incubated with 1 C i /ml radiolabeled thymidine ([methyl- 3 H]thymidine) for 120 min at 37°C. Culture dishes were rinsed once with ice-cold PBS, 1N perchloric acid, 0.5N perchloric acid, and 95% ethanol and solubilized with 0.3N NaOH for 30 min at 37°C. An aliquot (50 l) was used for cell protein determination, using the bicinchroninic assay (Pierce, Rockford, IL) (Goldschmidt and K imelberg, 1989 ). The remaining cell suspension was mixed with Ultima Gold, and radioactivity was determined with a scintillation counter.
T ime-lapse video microscopy. For time-lapse experiments astrocytes were cultured, plated, and maintained as described for electrophysiological recordings. Coverslips were scarred mechanically and placed on the stage of a LU-CB-1 tissue culture chamber (Medical Systems, Greenvale, N Y) equipped with an N P-2 incubator (Nikon, Japan), which maintained temperature at 37°C and atmosphere at 95% O 2 /5% C O 2 . C ells were visualized by a Nikon Diaphot inverted microscope with phase-contrast optics and a 20ϫ objective. Images were captured on a time-lapse V HS video recorder/player and digitized off-line by a frame grabber (Snappy). C ells were incubated with control growth media (see above) or growth media supplemented with 20 M cytosine ␤-D-arabinof uranoside (Ara-C), 2 mM 4-AP, 40 mM TEA, or 10 M TTX.
Statistical anal ysis. All statistical analysis was done with GraphPAD (InStat). Student's unpaired, two-tailed t test was used for data that followed normal SD distributions.
RESULTS
To study the membrane properties of astrocytes at gliotic scars, we used a culture model of glial cell injury recently characterized by Yu et al. (1993) . Purified primary cultures of neonatal spinal cord astrocytes were grown to confluency (Ͼ8 d in vitro) before being scarred mechanically by gently scratching the cell monolayer with a sterile pipette tip, resulting in scars that were 150 -200 m wide (Fig. 1 ). For simplicity, we refer to this injury as an in vitro glial scar without claiming that this injury model duplicates glial scarring in vivo. Astrocytes associated with the in vitro scar, however, display several of the hallmarks of gliosis in vivo, including upregulation of glial fibrillary acidic protein (GFAP; Fig.  1C ,D), cell proliferation (Fig. 3C,D) , and responsiveness to basic fibroblast growth factor (Yu et al., 1993; Hou et al., 1995) .
Using time-lapse video microscopy, we monitored scar closure as cells became confluent with the surrounding cell monolayer, which typically was achieved within 20 hr (Fig. 1 A) . Scar closure resulted from both migration and proliferation of scar-associated cells. C ell bodies routinely were observed condensing, roundingup, and pulling apart to give rise to sister cells (Fig. 2) . When cell proliferation was inhibited by incubation with the mitogenic inhibitor Ara-C (20 M), scar closure was delayed and greatly retarded ( Fig. 1 B) . Under those conditions scar closure primarily involved the migration of postmitotic cells into the scar, resulting in noticeably lower cell densities at the scar region ( Fig. 1 B at 20 hr).
To assess quantitatively the proliferation of astrocytes associated with the scar, we used BrdU and 3 H-thymidine, DNA markers that are incorporated selectively by dividing cells in S-phase. The monolayer of cells was incubated for 2 hr with BrdU labeling reagent and then stained for BrdU reactivity with a biotinylated anti-BrdU monoclonal and a streptavidin-peroxidase/DAB resolution kit with a hematoxylin counterstain. We used the same 2 hr BrdU labeling pulse for scarred coverslips, but we staggered the labeling episodes every 2 hr over the course of scar closure so that proliferation could be determined at any given time from 4 to 22 hr postinjury. Figure 3 shows photomicrographs with representative examples of BrdU immunoreactivity of scar-associated cells 14 hr postinjury (Fig. 3A) and noninjured control sister cultures (Fig. 3B ). BrdU-positive cells are depicted as dark nuclei resulting from the DAB reaction. Their number was greatly enhanced within 250 m from the scar, as compared with control cultures. The percentage of BrdU-positive cells was determined for eight random fields on both control and scarred coverslips at various times (4 -22 hr) after injury, and mean values were plotted in Figure 3C . In uninjured control cultures only 3% of cells were BrdU-positive after a 2 hr pulse of BrdU. This is similar to values previously reported for confluent spinal cord astrocytes (Pappas et al., 1994) . At 4 hr postinjury there was a twofold increase in the percentage of proliferating cells at the scar ( p ϭ 0.014); after 6 hr, proliferation was enhanced more than threefold ( p ϭ 0.006). This increase in the percentage of proliferating cells at the scar remained elevated for 22 hr postinjury. Cells within 250 m from the scar showed intense labeling with GFAP antibodies, as did the majority of the uninjured cell monolayer (Ͼ95%; Fig. 1C,D) .
Using 3 H ϩ -thymidine uptake as a quantitative marker for DNA synthesis, we determined the relative change in scar- induced glial proliferation over that of control sister cultures for the entire coverslip (Fig. 3D) . Because scars were inflicted after confluency had been reached (Ͼ8 d in vitro), proliferation rates before the insult were relatively small and accounted for Ͻ5% of the total proliferation observed at Ն3 d in vitro. Postinjury, proliferation showed a transient increase that peaked ϳ24 hr. Overall, proliferation increased by 10% (SD 5.5%) with a maximum increase of 35%. This transient rise in proliferation was inhibited completely by the antimitotic agent Ara-C (20 M), which also inhibited scar-associated proliferation during timelapse studies (Fig. 1 B) .
Changes in ion channel complement induced by in vitro scarring
Several studies have established independently that proliferating glial progenitors vary electrophysiologically from differentiated astrocytes or oligodendrocytes (Sontheimer et al., 1989; Ransom and Sontheimer, 1995; Roy and Sontheimer, 1995) , suggesting that the transition from progenitor to differentiated, nondividing cell correlates with profound changes in ion channel expression. In light of these findings, we were curious as to whether biophysical changes accompany dedifferentiation and injury-induced "secondary" proliferation of astrocytes. To assess such changes, we obtained whole-cell recordings at defined time periods over 32 hr postinjury. Individual cells were preincubated with BrdU labeling reagent for 2 hr, filled with L ucifer yellow during wholecell recording, and immunoreacted for BrdU postrecording. This allowed for the identification of individual cells and the correlation of their current profile to their proliferative status.
A representative example of a BrdU-positive cell recorded at a scar is shown in Figure 4 . Photomicrographs show the phase image (Fig. 4 A) , Lucifer yellow fill (Fig. 4 B) , and BrdU staining (Fig. 4C) . Although only the recorded cell was filled with Lucifer yellow, at least two neighboring cells were also BrdU ϩ . Shown in addition are representative whole-cell recordings characteristic of all BrdU-positive cells from which recordings were obtained (Fig.  4 D-I ). Of 317 scar-associated cells recorded, 58 were identified conclusively as BrdU-positive, 32 were BrdU-negative, and the rest either were not recovered for staining or were equivocal. The current-voltage relationship of BrdU ϩ cells consistently showed strong outward rectification (Fig. 4 D) . With both de-and hyperpolarizing voltage steps (10 msec), all BrdU ϩ cells expressed predominantly outward currents (Fig. 4 E) , with the predominant inward currents being sodium. To activate fully any inwardly rectifying potassium currents (K IR ), we used a voltage step protocol that depolarized the cell to 0 mV and then stepped the membrane to voltages between Ϫ10 and Ϫ180 mV. Although this protocol still activated outward K ϩ currents, it removed all transient outward current components. In response to this protocol, BrdU ϩ cells showed little K IR current (Fig. 4 F) . Figure 4 , G-I, shows the isolation of transient K ϩ current by standard proce- dures (Connor and Stevens, 1971) . Currents were recorded first from a prepulse potential of Ϫ110 mV. When a more depolarized prepulse (Ϫ50 mV) was applied, a transient outward potassium current that resembled the "A-type" current (K A ) was inactivated completely, and the sustained or "delayed" current (K D ) was isolated (Fig. 4 H) . Point-by-point subtraction of the current obtained with a prepulse of Ϫ50 mV from that obtained with the prepulse at Ϫ110 mV allowed for the isolation of this transient potassium current (Fig. 4 I) . Transient and sustained outward currents were differentially sensitive to TEA and 4-AP. As is the case for most neuronal A-currents (Rudy, 1988) , the transient outward potassium currents in astrocytes were insensitive to 40 mM TEA (Fig. 5B) but were inhibited almost completely by the addition of 2 mM 4-AP (Fig. 5C ). In contrast, sustained K ϩ currents were equally sensitive to TEA and 4-AP, each reducing currents by ϳ50%. TEA and 4-AP in combination essentially blocked all outward currents (Fig. 5) .
BrdU-negative cells express primarily inwardly rectifying potassium currents
For comparison, recordings were obtained from nonproliferating BrdU-negative cells on noninjured control coverslips. Figure 6 shows photomicrographs and representative recordings of a BrdU-negative cell. Micrographs A through C depict the Hoffman contrast, Lucifer yellow, and BrdU staining, respectively. A total of 111 control cells were recorded, of which 55 cells were identified unequivocally as BrdU-negative, whereas the remainder were either BrdU-positive or equivocal. We applied the same voltage step protocols described for scar-associated cells. The currentvoltage relationship (Fig. 6 D) showed marked inward rectification. Both inward and outward currents could be identified by 80 msec voltage steps ranging from Ϫ130 to 100 mV (Fig. 6 E) . Because the outward current activated by this protocol was much smaller than the inward current, these currents were not leaksubtracted. Voltage protocols to isolate transient outward cur- rents revealed the consistent presence of A-currents in these cells (Fig. 6 F) , which, as in BrdU ϩ cells, was sensitive to 4-AP (data not shown). Large, inwardly rectif ying potassium currents (K IR ) were activated when a prepulse of 0 mV was applied and cells were stepped to more negative potentials (Fig. 6G) . This K IR current was identical in its kinetics and voltage dependence to those previously described for spinal cord astrocytes in vitro and in situ (Sontheimer et al., 1992; Ransom and Sontheimer, 1995) . As we (Ransom and Sontheimer, 1995) and others (Barres et al., 1988; Tse et al., 1992; Newman, 1993) have described previously, K IR currents were highly sensitive to 100 M extracellular Cs ϩ (Fig. 6G) .
Interestingly, BrdU Ϫ cells associated with the scar expressed K IR currents at comparable conductance density (1.07 pS/pF Ϯ (insets to the right) . D, The current-voltage relationship showed that BrdU-positive cells demonstrate predominantly outward currents. E, Inward sodium currents and large outward potassium currents were activated by hyperpolarizing and depolarizing voltage steps. F, A tail current protocol elicited virtually no inwardly rectif ying potassium currents in proliferating cells. G, Transient and sustained outwardly rectifying potassium currents were elicited in proliferating cells. H, The sustained current was isolated by depolarizing steps from a Ϫ50 mV prepulse. Point-by-point subtraction of the sustained current from the composite outward current allowed for the isolation of the transient outward potassium current (G Ϫ H ϭ I ). 0.2, n ϭ 32) to those of nonscarred controls (1.30 pS/pF Ϯ 0.2). Similarly, the K IR conductance density of control cells that were BrdU ϩ (0.47 pS/pF Ϯ 0.1, n ϭ 10) was comparable to that seen in scar-associated cells (0.45 pS/pF Ϯ 0.05), suggesting that the proliferative state rather than the preceding injury determines K IR current expression.
Sodium currents in scar-associated versus control cells
In 79% of scar-associated and ϳ45% of control cells, transient inward currents could be evoked by 8 msec depolarizing voltage steps from Ϫ70 to 80 mV, preceded by a prepulse of Ϫ110 mV (Fig. 7A) . Using isolation solutions, we determined the steadystate inactivation of these currents by using a protocol that applied varied prepulse potentials between Ϫ160 and Ϫ30 mV (200 msec), followed by a step at which currents were maximally activated (Ϫ10 mV) (Fig. 7B) . In both proliferating and nonproliferating cells, currents activated at approximately Ϫ40 mV, peaked near Ϫ10 mV, and reversed at 60 mV, which is near the predicted reversal potential for Na ϩ ions (65 mV) ( Fig. 7C ; n ϭ 11). We also determined steady-state activation and inactivation of sodium currents for control (Fig. 7D ) and scar-associated cells (Fig. 7E) . The half-maximal inactivation was Ϫ66 mV in control cells (n ϭ 4) and Ϫ60 mV in scar-associated cells (n ϭ 8); values for half-maximal activation were Ϫ35 mV (n ϭ 4) and Ϫ25 mV (n ϭ 13), respectively. To confirm that these currents were mediated by Na ϩ channels, we applied 10 M TTX, which completely inhibited currents on both control and scar-associated coverslips (Fig. 7F,G) .
To compare changes in ion channel expression between BrdUpositive and BrdU-negative cells, we determined specific conductance densities for each of the current components by dividing conductances by whole-cell capacitance (pS/pF). These values, along with resting membrane potential and whole-cell capacitance values, were summarized and analyzed statistically (Table  1) . BrdU-positive cells were significantly smaller in cell size, as measured by membrane capacitance, and had significantly more positive resting potentials than nonproliferating cells. Moreover, there was a striking twofold increase in the specific conductance of both the sustained (K D ) and transient (K A ) outward potassium currents in BrdU-positive cells ( p Ͻ 0.0001 for both). In addition, there was a twofold increase in sodium conductance in BrdUpositive cells ( p ϭ 0.041). The most dramatic difference observed was with respect to changes in K IR conductance. In proliferating cells, it decreased to 35% of that in nonproliferating cells ( p Ͻ 0.0001). We saw no significant difference between the two groups in terms of outward potassium/sodium conductance ratios (G K D / G Na and G Ktotal /G Na ); however, the ratio of G K IR /G Na was significantly larger in nonproliferating cells ( p ϭ 0.003), which indicates that these cells have a much larger inward potassium current at rest.
Electrophysiological changes over time postinjury
To assess the time over which these electrophysiological changes occurred after injury, we determined the changes in the conductance densities of the various current types as a function of time postinjury. This analysis was restricted to those cells unequivocally identified as BrdU ϩ (n ϭ 58) or BrdU Ϫ (n ϭ 55). Mean values of conductance densities for the four main current types described were plotted as a function of time postinjury for BrdU ϩ and BrdU Ϫ cells ( Fig. 8 ; BrdU Ϫ values ϭ 0 hr postscar). These data suggest that electrophysiological changes are rapid, with the most significant changes in the membrane properties of proliferating cells occurring within 4 hr postinjury. With the exception of K IR , all other conductances return nearly to control values within 24 hr postinjury, a time at which scar closure is complete (see Fig. 1 ). A twofold increase in the specific conductance of the K D (Fig. 8, filled squares) was observed at 4 hr postinjury ( p ϭ 0.0005). Likewise, a significant increase in the specific conductance of the K A current (Fig. 8, filled circles) was seen within 4 hr ( p ϭ 0.05); however, the maximal increase over control conductance values was seen at 6 hr postscar ( p ϭ 0.002). Sodium conductances (Fig. 8, shaded triangles) also increased A-E, The isolated transient and sustained outwardly rectif ying potassium currents from a typical scar-associated cell (6 hr postinjury) recorded before and after the application of potassium channel blockers, as indicated. A, In normal recording solution large transient and sustained currents are recorded. B, Application of 40 mM TEA inhibited the sustained K ϩ current by ϳ50% but had no effect on the transient current. C, The addition of 4-AP (2 mM) completely inhibited the transient potassium currents and also inhibited the residual sustained K ϩ current that was not inhibited by TEA. D, To demonstrate that 4-AP inhibition of the sustained current is specific and not attributable to current rundown or time-dependent TEA inhibition, we show that, in the absence of 4-AP but in the presence of TEA, currents recover to levels previously seen in the presence of TEA alone. E, Currents show partial recovery on removal of potassium channel blockers. A-E, n ϭ 14.
significantly within 4 hr ( p ϭ 0.05) and reached maximal values over control at 6 hr postinjury ( p Ͻ 0.0001). A significant decrease in the conductance of the K IR (Fig. 8, x) was observed as early as 4 hr postscar ( p ϭ 0.05) and remained significantly decreased even at 24 hr postinjury ( p ϭ 0.03).
K
؉ channel activity is required for astrocyte proliferation and scar closure Because we observed changes in the relative expression of Na ϩ and K ϩ channels in cells that were induced to proliferate, we used time-lapse video microscopy to investigate whether selective pharmacological blockade of Na ϩ or K ϩ channels affected in vitro scar closure (Fig. 9 ) Injury in the presence of growth medium alone resulted in rapid scar closure (20 hr). Scar closure was retarded when growth medium was supplemented with 2 mM 4-AP, which partially blocks sustained outwardly rectifying potassium currents and completely blocks A-type K ϩ currents (Fig.  9B ). Proliferation and scar closure also were inhibited by TEA (40 mM), which selectively blocked only the sustained outwardly rectifying potassium currents (Fig. 9C) . These data suggest that the activity of the sustained outwardly rectifying K ϩ channels, in 
insets to right). D,
The current-voltage relationship demonstrated predominantly inwardly rectif ying conductance. E, Both inward and outward potassium currents were elicited by hyperpolarizing /depolarizing voltage steps. In this example, no detectable sodium currents were seen; however, ϳ45% of nonproliferating cells demonstrate I Na ϩ. F, Outward currents were mediated predominantly by transient potassium currents shown after point-by-point subtraction (see Results). G, A tail current protocol typically elicited large K IR currents in BrdU-negative cells. These currents were sensitive to 100 M Cs ϩ and demonstrated partial recovery on its removal (n ϭ 8).
particular, was essential to the process of injury-induced astrocyte proliferation and scar closure. In comparison, 10 M TTX did not affect scar closure, and complete confluence was achieved after 20 hr, as in control conditions. This suggests that, although sodium conductance was augmented in scar-associated cells, blockade of these currents did not deter proliferation.
DISCUSSION
This study demonstrates considerable electrophysiological changes in astrocytes undergoing injury-induced secondary proliferation. Proliferation was associated with a switch in K ϩ current expression: outwardly rectifying potassium currents were upregulated with a concurrent downregulation of inwardly rectifying potassium currents. In addition, scar-associated cells exhibited increased sodium conductance. These changes were transient and occurred within a few hours after the insult. Blockade of outwardly rectifying K ϩ channels by TEA or 4-AP inhibited glial proliferation and retarded scar repair, whereas blockade of Na ϩ channels with TTX was ineffective, suggesting that K ϩ channel activity is of particular functional importance in injury-induced proliferation and scar repair in vitro. Indeed, our pharmacological Figure 7 . Sodium currents in scar-associated and control cells. A, Activation of Na ϩ currents was studied using a protocol of a prepulse at Ϫ110 mV to remove sodium inactivation and then steps to voltages ranging from Ϫ70 to 80 mV. B, Steady-state inactivation of Na ϩ currents was determined by applying a varied prepulse potential ranging from Ϫ160 to Ϫ30 mV, followed by a voltage step at which sodium currents were maximally activated (Ϫ10 mV). C, The peak I Na ϩ amplitude was averaged for 11 cells and plotted as a f unction of voltage. Sodium currents activated at approximately Ϫ40 mV reached a maximum near Ϫ10 mV and reversed at 60 mV, which is close to the E Na of 65 mV. D, E, For inactivation curves the normalized peak current for each cell (n ϭ 6) was plotted as a f unction of membrane potential, and each was fit to the Boltzmann equation. The mean normalized peak current and mean Boltzmann fit were graphed. For the activation curve normalized peak conductance was plotted versus membrane potential, and the mean of the individual activation curves and the mean Boltzmann fit were graphed. The half-maximal inactivation was Ϫ66 mV in control cells (n ϭ 4) and Ϫ60 mV in scar-associated cells (n ϭ 8); values for half-maximal activation were Ϫ35 mV (n ϭ 4) and Ϫ25 mV (n ϭ 13), respectively. F, G, Sodium currents in both control and scar-associated cells were inhibited completely by 10 M TTX.
analysis suggests that K D currents, which are sensitive to both TEA and 4-AP, are of key importance in proliferation.
The in vitro model used does not do justice to the complex cell -cell interactions that underlie gliosis in vivo. Nevertheless, in vitro scars show some of the hallmarks described for glial scars in vivo, including GFAP upregulation and increased mitosis (Yu et al., 1993) . Our cultures did not contain neurons, and, consequently, our scars could not respond to messengers released by dying neurons. Glial scars in vivo, however, also are devoid of neurons and provide a relatively pure glial environment. Although the limitations of the model constrain the interpretation of our results as they pertain to gliosis in vivo, the simplicity of the model allowed for the assessment of injury under conditions than would not be possible in vivo. Moreover, it permitted the assessment of scar closure via time-lapse video microscopy, which would not readily be possible in vivo. Despite limitations, we are encouraged that the findings of this study also may apply to in vivo gliosis. Astrocytes acutely isolated from gliotic tissue of patients with intractable epilepsy showed a conspicuous absence of K IR channels and an upregulation of Na ϩ channels (de Lanerolle et al., 1994) , which is consistent with the present data. Furthermore, the decrease in K IR during gliosis may explain why gliotic tissue in experimental models of epilepsy demonstrate impaired potassium clearance (Lewis et al., 1977) , because K IR channels are believed to be of key importance in potassium buffering (Newman, 1993; Ransom and Sontheimer, 1995) . C learly, our future studies must evaluate gliosis by in vivo methods.
Electrophysiological changes in gliosis mirror those associated with gliogenesis
Changes in the electrophysiological properties of glial cells during development have been studied extensively in vitro. Most notably, O-2A glial progenitor cells express K D , K A , and Na ϩ currents but, on commitment to the oligodendrocyte lineage, express primarily K IR currents (Bevan et al., 1987; Sontheimer et al., 1989; Barres et al., 1990a,b) . In vitro, spinal cord astrocytes switch from outwardly to inwardly rectifying K ϩ currents at 4 -7 d in vitro (Roy and Sontheimer, 1995) . Similarly, 50% of hippocampal astrocytes in situ lack K IR currents in slices from postnatal day 5 (P5) rats, a time at which many astrocytes are still mitotically active, but virtually all astrocytes acutely dissociated (Tse et al., 1992) or in acute slices of animals ϾP14 express K IR currents (Kressin et al., 1995; Bordey and Sontheimer, 1996) . The observed loss of K IR and upregulation of K D and K A after injury thus can be interpreted as a recapitulation of the more immature current profile seen during development, wherein the majority of astrocytes is mitotically active. , which nonselectively blocks outwardly rectifying potassium channels. C, Scar proliferation also was primarily inhibited by TEA (40 mM), which selectively inhibits the sustained outwardly rectifying potassium current. D, In contrast, 10 M TTX, a concentration that completely inhibited all sodium currents, had no inhibitory effect on scar repair. Results suggest that astrocyte proliferation depends particularly on the activity of sustained outward K ϩ channels and not on the activity of Na ϩ channels. Scale bar, 100 m.
Changes in K
؉ channel activity accompany cell cycle: a common phenomenon A f unctional relationship between K ϩ channel activity and cell proliferation was demonstrated first in lymphocytes (DeCoursey et al., 1984) , where pharmacological blockade of outwardly rectifying K ϩ currents inhibited cell proliferation. Numerous studies have demonstrated since then that blockade of outward potassium currents is also antiproliferative for brown fat cells (Pappone and Ortizmiranda, 1993) , melanoma cells (Nilius and Wohlrab, 1992) , human breast cancer cells (Woodfork et al., 1995) , retinal glial cells (Puro et al., 1989) , Schwann cells (Chiu and Wilson, 1989) , O2-A progenitor cells (Gallo et al., 1996) , and astrocytes (Pappas et al., 1994) . C ell cycle-dependent changes in K ϩ current expression have been studied more directly in a few cell preparations, which provide evidence for a loss of K IR activity during proliferation, consistent with our data. For example, proliferating human leukemia cells generally lack expression of K IR currents, but currents are upregulated rapidly on induction to differentiate into macrophages (Wieland et al., 1990) . Mouse embryos (Day et al., 1993) , HeLa cells (Takahashi et al., 1994) , and neuroblastoma cells (Arcangeli et al., 1995) all exhibit a downregulation of K IR currents on entrance into S-phase of cell cycle. These studies and ours suggest that differentiated, postmitotic cells express K IR channels as their major channel type, whereas proliferating cells show upregulation of K D and a loss of K IR .
The mechanism by which changes in K ϩ channel complement translate into an altered proliferative status is unclear. It is important to note that no conclusive "mechanistic" explanation has been provided to date. It seems indisputable, however, that K ϩ channel activity follows a pattern of expression in dividing versus nondividing cells that is independent of the mode of proliferation, be it primary (development), secondary (injury-induced), or cancerous. In the absence of any mechanistic explanation, we hypothesize that the observed changes in astrocyte ion channel complement do not cause altered cell cycle progression; rather, altered K ϩ channel activity establishes an appropriate intracellular ionic milieu that aids cell proliferation.
A relationship between membrane potential and cell proliferation was proposed first by Cone (1970) , showing that cancerous cells are more depolarized than noncancerous cells. Similarly, glial progenitor cells are consistently 20 mV more depolarized than are oligodendrocytes or astrocytes (Sontheimer et al., 1989) . A recent study showed that proliferation of O-2A cells could be inhibited by numerous depolarizing reagents, including conditions that increased intracellular Na ϩ (Knutson et al., 1997) , suggesting that O-2A proliferation is controlled by changes in membrane potential. Yet, two studies in astrocytes (Pappas et al., 1994) and Schwann cells (Moor and Cole, 1963) showed antiproliferative effects of K ϩ channel blockers even in the absence of significant membrane depolarization. Taken together, membrane potential changes may be important in the cell cycle regulation of some cells; however, the mechanisms by which changes in membrane potential lead to altered gene expression are unknown. It has been suggested that more depolarized membrane potentials lead to increased [Na ϩ ] i and [C a 2ϩ ] i . Changes in [C a 2ϩ ] i have been associated with cell cycle progression in a number of cell types (Lewis and C ahalan, 1990; Means, 1994; Baran, 1996; Isfort et al., 1996) . Surprisingly, however, studies investigating such a relationship in glial progenitor cells (Knutson et al., 1997) and astrocytes (Pappas et al., 1994) failed to show a conclusive dependence of cell cycle progression on changes in [C a 2ϩ ] i . Alterations in intracellular ions may induce gene expression, providing an attractive framework to explore f urther the interdependence among K ϩ channel expression, membrane depolarization, [Na ϩ ] i , [Ca 2ϩ ] i , and cell proliferation. Using a combination of electrophysiological recordings and ratiometric fluorescence imaging, Pappas et al. (1994) showed that the antiproliferative effect of blocking K ϩ channels is correlated with an alkaline shift in pH i . These authors proposed that leakage of H ϩ through K ϩ channels may modulate pH i , which in turn establishes conditions that are either permissive or nonpermissive for astrocyte proliferation. Consistent with this model, alkaline pH i shifts inhibit astrocyte proliferation even in the absence of ion channel blockers (Pappas et al., 1994) .
Some studies are shedding light on the interactions among oncogenes, tumor suppressor genes, and ion channel function. The transfection of fibroblasts with ras21 or exposure of fibroblasts to epidermal growth factor or platelet-derived growth factor leads to the induction of a novel Ca 2ϩ -activated K ϩ channel that is essential for cell cycle progression in these cells (Huang and Rane, 1994) . In Drosophila, the tumor suppressor gene dlg interacts with A-type K ϩ channels, leading to channel clustering (Tejedor et al., 1997) . Clearly, further studies are needed to establish how changes in K ϩ channel expression may translate into altered gene expression and cell proliferation.
Na

؉ currents
Although Na ϩ channel activity is markedly upregulated at the scar and is expressed in the majority of scar-associated cells, their functional role is unclear. Pharmacological blockade of Na ϩ channels by 10 M TTX had no effect on astrocyte proliferation at the scar and did not affect scar repair. Thus, the antiproliferative effects of both TEA and 4-AP suggest that inhibition of the K D current alone is effective in hindering the processes of astrocyte proliferation and scar repair.
Implications
Gliosis accompanies not only acute trauma but a number of chronic conditions, including Alzheimer's disease, stroke, and epilepsy. The question of whether glial scarring is beneficial or detrimental to f unctional recovery after injury has been raised frequently (Hatten et al., 1984; Reier, 1986 ), yet no conclusive answer has been provided. It has been demonstrated convincingly that astrocytes forming glial scars retard neurite outgrowth. This is, in part, the result of astrocytes forming a physical barrier that prevents penetration of neurites, but it is also attributable to the release of modulatory extracellular matrix molecules (Reier, 1986; C anning et al., 1996) , neurotrophic factors (Winter et al., 1995) , and cytokines (Selmaj et al., 1990; Giulian et al., 1994) . On the basis of these data one would expect that inhibition of gliosis should facilitate f unctional recovery after injury. A better understanding of the physiological and molecular processes associated with injuryinduced astrocyte proliferation may provide an avenue for the suppression of glial scar formation.
